Reinsurers must adapt strategies to align with risk introduced by GLP-1 therapies: Gallagher Re
Reinsurance News - Mar 28, 2025
Gallagher Re, a reinsurance brokerage and risk management services provider, has released a report on the impact of GLP-1 receptor agonists on medical trends and reinsurance. According to the report, as these therapies continue to reshape medical trends and insurance structures, reinsurance provider...
Recommended Articles
Posted: Apr 16, 2026
Capgemini Research Institute, the research division of the Capgemini, has published the report Physi...
Posted: Apr 16, 2026
Beazley, a large specialist insurer, has announced plans to establish a new Marine War insurance con...
Posted: Apr 16, 2026
John Doyle, President and Chief Executive Officer (CEO) of global insurance and reinsurance broking...